Clinical trial
A Real-World Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin
NCT06716645 is registered in ClinicalTrials.gov with HALEON as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Real-World Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin
- Lead sponsor
- HALEON
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 4, 2024
- Completion date
- February 14, 2025
- Enrollment
- 244 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.